Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Feideli Pharmaceutical is a large-scale pharmaceutical enterprise based in Neijiang, Sichuan, specializing in the research, production, and sale of biochemical raw materials and finished drug preparations. Originally founded in 1976 as the state-owned Neijiang Biochemical Pharmaceutical Factory, the company has established itself as a leading producer of artificial bezoar in China. Its extensive product portfolio includes over 40 varieties across multiple dosage forms, such as Multienzyme Tablets, Pepsin Tablets, and Thyroid Powder. The company operates a GMP-certified manufacturing facility and exports biochemical APIs like thyroid powder and pepsin to international markets. Feideli continues to focus on the development of biochemical extracts and traditional Chinese medicine formulations to address digestive and metabolic health needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Feideli Pharmaceutical.